| Category | Min Lots | Shares | Amount |
|---|---|---|---|
| Retail (sNII) | 2 | 3,200 | ₹2,72,000 |
| HNI / NII | 3 | 4,800 | ₹4,08,000 |
| Category | Sub (×) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 13,32,800 (40.28%) | — | ₹1,132.88 Cr |
| NII / HNI (Total) | — | 5,42,400 (16.39%) | — | ₹461.04 Cr |
| Retail Investors | — | 12,67,200 (38.30%) | — | ₹1,077.12 Cr |
| Total ** | — | 33,08,800 (100.00%) | — | ₹28,124.80 Cr |
| Market Maker * | — | 1,66,400 (5.03%) | — | ₹14.14 Cr |
| Metric | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 17.08 | 30.18 | 15.90 |
| PAT | 4.08 | 4.93 | 3.81 |
| EBITDA | 6.77 | 9.20 | 7.09 |
| Net Worth | 23.68 | 13.60 | 8.67 |
| Total Assets | 34.90 | 21.22 | 15.89 |
| Reserves | 14.42 | 5.18 | 8.54 |
| Borrowings | 3.72 | 3.54 | 3.81 |
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
As of October 31, 2025, the company employed 157 permanent employees.
Competitive Strength: